Published in J Infect Dis on April 01, 1999
Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol (2011) 2.81
Coevolutionary patterns in plasminogen activation. Proc Natl Acad Sci U S A (2003) 1.22
Role of the C-terminal lysine residues of streptococcal surface enolase in Glu- and Lys-plasminogen-binding activities of group A streptococci. Infect Immun (2004) 1.19
Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection. Infect Immun (2004) 1.09
Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation. Infect Immun (2009) 1.01
Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. J Biomed Biotechnol (2012) 1.01
Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis. J Infect Dis (2007) 0.97
Molecular cloning and characterization of two Helicobacter pylori genes coding for plasminogen-binding proteins. Proc Natl Acad Sci U S A (2004) 0.95
Group B Streptococcus hijacks the host plasminogen system to promote brain endothelial cell invasion. PLoS One (2013) 0.84
Plasminogen binding proteins and plasmin generation on the surface of Leptospira spp.: the contribution to the bacteria-host interactions. J Biomed Biotechnol (2012) 0.82
Restoration of Mga function to a Streptococcus pyogenes strain (M Type 50) that is virulent in mice. Infect Immun (2001) 0.81
The role of coagulation/fibrinolysis during Streptococcus pyogenes infection. Front Cell Infect Microbiol (2014) 0.80
Binding and activation of host plasminogen on the surface of Francisella tularensis. BMC Microbiol (2010) 0.77
Pathogen activators of plasminogen. J Thromb Haemost (2015) 0.76
The Mechanisms of Virulence Regulation by Small Noncoding RNAs in Low GC Gram-Positive Pathogens. Int J Mol Sci (2015) 0.75
In Vivo Tracking of Streptococcal Infections of Subcutaneous Origin in a Murine Model. Mol Imaging Biol (2015) 0.75
Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol (2001) 2.24
Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol (1992) 2.14
Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun (1993) 1.92
Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood (1998) 1.81
Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol (1994) 1.76
Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun (1987) 1.72
M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol (1996) 1.71
The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol (2000) 1.51
Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res (2000) 1.46
Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol (1999) 1.39
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med (1997) 1.38
Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same micro-organism. J Biol Chem (1991) 1.38
A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol (1998) 1.36
Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am J Pathol (2001) 1.34
Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J Immunol (1984) 1.33
A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost (2004) 1.22
Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus. Microb Pathog (1988) 1.20
Isolation and characterization of type IIa and type IIb Fc receptors from a group A streptococcus. Scand J Immunol (1986) 1.18
Effect of mouse passage on Fc receptor expression by group A streptococci. Scand J Immunol (1984) 1.15
Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. J Infect Dis (1992) 1.15
Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun (2000) 1.13
Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen. Infect Immun (1989) 1.12
Protection of mice from group A streptococcal skin infection by interleukin-12. J Infect Dis (1995) 1.12
125I protein A: applications to the quantitative determination of fluid phase and cell-bound IgG. J Immunol Methods (1977) 1.10
Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood. Infect Immun (1993) 1.10
A coagulation factor VII deficiency protects against acute inflammatory responses in mice. J Pathol (2006) 1.09
Studies on the terminal stages of immune hemolysis. VI. Osmotic blockers of differing Stokes' radii detect complement-induced transmembrane channels of differing size. J Immunol (1979) 1.09
A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator. Thromb Haemost (1988) 1.09
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol (1992) 1.08
Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis (1988) 1.07
Measurement of leukocyte chemotaxis in vivo. Methods Enzymol (1988) 1.07
Isolation and partial characterization of a type II Fc receptor from a group A streptococcus. Mol Cell Biochem (1986) 1.07
Streptococcal Fc receptors. II. Comparison of the reactivity of a receptor from a group C streptococcus with staphylococcal protein A. J Immunol (1984) 1.06
Evidence for functional heterogeneity in IgG Fc-binding proteins associated with group A streptococci. J Immunol (1991) 1.05
Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis (1991) 1.04
Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci. Infect Immun (1989) 1.02
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel. J Immunol (1978) 1.02
Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis (1996) 0.99
Detection of receptors for the Fc region of IgG on streptococci. J Immunol Methods (1983) 0.99
Isolated DNA repeat region from fcrA76, the Fc-binding protein gene from an M-type 76 strain of group A streptococci, encodes a protein with Fc-binding activity. Mol Microbiol (1990) 0.99
Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor. J Biol Chem (1987) 0.99
A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. J Infect Dis (1995) 0.98
Identification of a unique receptor on a group A streptococcus for the Fc region of human IgG3. J Immunol (1986) 0.98
The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods (2000) 0.98
A group A streptococcal Enn protein potentially resulting from intergenomic recombination exhibits atypical immunoglobulin-binding characteristics. Mol Microbiol (1994) 0.97
The protein C pathway and pathologic processes. J Thromb Haemost (2009) 0.97
Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. Microb Pathog (1995) 0.97
Studies on the interaction between protein A and immunoglobulin G. II. Composition and activity of complexes formed between protein A and IgG. J Immunol (1978) 0.96
Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1985) 0.96
Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal. J Immunol (1979) 0.96
Differences in cell-bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9. J Immunol (1980) 0.95
Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis (1997) 0.95
Mouse skin passage of a Streptococcus pyogenes Tn917 mutant of sagA/pel restores virulence, beta-hemolysis and sagA/pel expression without altering the position or sequence of the transposon. BMC Microbiol (2001) 0.95
Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event? J Immunol (1976) 0.94
Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci U S A (1983) 0.94
Production of Brucella abortus-specific protein A-reactive antibodies (IgG2) in infected and vaccinated cattle. Vet Microbiol (1986) 0.94
Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis (1994) 0.94
Delayed inflammatory responses to endotoxin in fibrinogen-deficient mice. J Pathol (2006) 0.93
Ovulation in plasminogen-deficient mice. Endocrinology (1999) 0.93
Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1987) 0.93
Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. II. Inhibition of transformation of T to dead cells by 3'5' cAMP. J Immunol (1976) 0.92
A simple procedure to use whole serum as a source of either IgG- or IgM-specific antibody. J Immunol Methods (1980) 0.92
The generation and characterization of mice expressing a plasmin-inactivating active site mutation. J Thromb Haemost (2010) 0.92
Similarities between complement-mediated and streptolysin S-mediated hemolysis. J Biol Chem (2001) 0.91
A role of plasminogen in atherosclerosis and restenosis models in mice. Thromb Haemost (1999) 0.90
Analysis of surface receptor expression on bacteria isolated from patients with endocarditis. J Gen Microbiol (1986) 0.90
Interaction between components of the human classical complement pathway and immobilized Cibacron Blue F3GA. J Immunol Methods (1979) 0.90
Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. J Infect Dis (2001) 0.90
The terminal stages of immune hemolysis--a brief review. Mol Immunol (1980) 0.89
Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma. Infect Immun (1999) 0.89
A rapid technique for measuring leukocyte chemotaxis in vivo. J Immunol Methods (1984) 0.89
Identification of protein A from Staphylococcus intermedius isolated from canine skin. Am J Vet Res (1988) 0.89
Development of pulmonary fibrosis in fibrinogen-deficient mice. Ann N Y Acad Sci (2001) 0.89
The characterization of mice with a targeted combined deficiency of protein c and factor XI. Am J Pathol (2001) 0.88
Analysis of immunoglobulin G-binding-protein expression by invasive isolates of Streptococcus pyogenes. Clin Diagn Lab Immunol (1995) 0.88
Studies on the terminal stages of immune hemolysis. IV. Effect of metal salts. J Immunol (1979) 0.88
Analysis of expression of a cytosolic enzyme on the surface of Streptococcus pyogenes. Biochem Biophys Res Commun (2000) 0.88
Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structures. Microb Pathog (1998) 0.87
Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells. J Immunol (1976) 0.87
The existence of independent domain structures in human Lys77-plasminogen. J Biol Chem (1981) 0.87
Calorimetric evaluation of the existence of separate domains in bovine prothrombin. Biochemistry (1981) 0.86
A pivotal role for interferon-gamma in protection against group A streptococcal skin infection. J Infect Dis (2000) 0.86
Comparison of type III Fc receptors associated with group C and group G streptococci. Mol Immunol (1986) 0.86
Distinct profiles of immunoglobulin G-binding-protein expression by invasive serotype M1 isolates of Streptococcus pyogenes. Clin Diagn Lab Immunol (1995) 0.85
Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG. J Immunol (1978) 0.85
Results of the premature birth national need-gap study. J Perinatol (2007) 0.85
Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. I. Evidence for the existence of an intermediate, T. J Immunol (1976) 0.85
Enzyme-labeled type III bacterial Fc receptors. A versatile tracer for immunoassay. J Immunol Methods (1988) 0.84
The bovine mucosal disease-swine fever virus complex in pigs. Aust Vet J (1968) 0.84
Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiency. J Pediatr (1984) 0.84
Identification of distinct Fc-receptor molecules on streptococci and staphylococci. J Clin Lab Immunol (1984) 0.84
Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release. J Immunol (1980) 0.84
Targeting plasminogen activator inhibitor-1: role in cell signaling and the biology of domain-specific knock-in mice. Curr Drug Targets (2007) 0.84
Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci. J Infect Dis (1996) 0.84
Restoration of thrombolytic potential in plasminogen-deficient mice by bolus administration of plasminogen. Blood (1996) 0.84
Inactivation of single genes within the virulence regulon of an M2 group A streptococcal isolate result in differences in virulence for chicken embryos and for mice. Microb Pathog (1997) 0.84
Infection of pregnant ewes with mucosal disease virus of ovine origin. Aust Vet J (1974) 0.83
Expression of human plasminogen cDNA in a baculovirus vector-infected insect cell system. Arch Biochem Biophys (1989) 0.83